Electrophoresis Market Share, Trends and Industry Overview 2030

 

The Global Electrophoresis Market was valued at USD 3.29 billion in 2024 and is projected to reach USD 4.49 billion by 2030, growing at a CAGR of 5.62% from 2025 to 2030. This steady growth is driven by the rising demand for advanced diagnostic tools, increasing investments in biotechnology and healthcare research, and the growing necessity for accurate and efficient protein and nucleic acid analysis. Electrophoresis has become a critical technique in the life sciences, playing an essential role in drug development, disease diagnosis, genetic analysis, and academic research, thereby fueling the adoption of more sophisticated and high-throughput electrophoresis systems. As global focus intensifies on precision medicine, genomics, and molecular biology, the demand for reliable systems that can effectively separate and analyze proteins, DNA, and RNA continues to expand.

The degree of innovation in the electrophoresis market is notably high, with rapid technological advancements aimed at improving speed, accuracy, sensitivity, and efficiency. Modern developments include automated electrophoresis systems, high-resolution gel electrophoresis, and capillary electrophoresis techniques, which not only deliver enhanced analytical performance but also minimize the likelihood of human error. Furthermore, emerging technologies such as microfluidic devices and lab-on-a-chip systems are increasingly being integrated into electrophoresis instruments, enabling more precise analysis while requiring smaller sample volumes and reducing overall costs. Industry leaders such as Bio-Rad Laboratories and Thermo Fisher Scientific continue to launch innovative products equipped with advanced features, thereby accelerating the market’s growth trajectory.

Key Market Trends & Insights:

• Regional Insights: North America accounted for the largest revenue share of 35.41% in 2024, driven by its strong healthcare infrastructure, well-established biotechnology sector, and extensive investments in research. The Asia Pacific region is expected to record the fastest CAGR over the forecast period, fueled by rising government funding, rapid expansion of biotech companies, and growing emphasis on healthcare innovation in countries like China, India, and Japan.
• Product Insights: The electrophoresis reagents segment dominated the market with a 41.85% share in 2024, highlighting the indispensable role of reagents in ensuring the success and reproducibility of electrophoresis techniques.
• Application Insights: The research applications segment held the leading share of 52.65% in 2024, reflecting the technique’s widespread use in academic research, genomics, proteomics, and drug discovery. This segment is also anticipated to grow at the fastest pace in the forecast period due to increasing global research activities.
• End-use Insights: The pharmaceutical and biotechnology companies segment dominated with a 43.71% share in 2024 and is expected to expand rapidly as these companies increasingly rely on electrophoresis for drug development, biomarker discovery, and quality control testing.

Order a free sample PDF of the Electrophoresis Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 3.29 Billion
• 2030 Projected Market Size: USD 4.49 Billion
• CAGR (2025-2030): 5.62%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

The global electrophoresis market is highly competitive and includes major players such as Thermo Fisher Scientific, Bio-Rad Laboratories, GE Healthcare, Agilent Technologies, and Merck KGaA, which dominate due to their comprehensive product portfolios, strong R&D investments, and global presence.

• Thermo Fisher Scientific is recognized for its wide range of systems and reagents, catering to both research and diagnostic applications, and consistently invests in innovation to enhance product performance.
• Bio-Rad Laboratories is well-known for its advanced gel and automated capillary electrophoresis systems, widely used across genomics, proteomics, and clinical diagnostics.
• Agilent Technologies specializes in high-performance capillary electrophoresis systems designed for analyzing proteins, nucleic acids, and other biomolecules with high precision.
• Merck KGaA offers an extensive selection of reagents, kits, and consumables tailored to applications in molecular biology, drug discovery, and clinical diagnostics.

These key players are shaping the industry by focusing on technological advancements, expansion of product offerings, and maintaining strict quality standards, ensuring that the growing demand for electrophoresis solutions is met globally. Alongside established leaders, emerging companies and regional players are also entering the market, especially in Asia Pacific, thereby enhancing competition and driving innovation.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global electrophoresis market is poised for steady growth, supported by rising investments in biotechnology, healthcare research, and the increasing demand for advanced diagnostic and analytical tools. With innovations such as automated systems, microfluidics, and lab-on-a-chip technologies enhancing precision and efficiency, electrophoresis continues to be an indispensable tool in drug development, disease diagnosis, and genetic research. Backed by strong contributions from key players and expanding adoption across both developed and emerging regions, the market is set to advance as a vital enabler of progress in life sciences and precision medicine.